GridAI Technologies (GRDX) Return on Capital Employed (2016 - 2025)
GridAI Technologies' (GRDX) quarterly Return on Capital Employed came in at 9.22% in Q4 2025, up 1768.0% YoY from 0.49% in Q4 2024, and down 96.58% on a QoQ basis from 4.69% in Q3 2025.
GridAI Technologies (GRDX) Return on Capital Employed (2016 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 10 years of Return on Capital Employed data on file, last reported at 9.22% in Q4 2025.
- Quarterly Return on Capital Employed rose 1768.0% year-over-year to 9.22% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 9.22% (up 1768.0% YoY) and the FY2025 annual result came in at 13.67%, up 7032.0% from the prior year.
- Return on Capital Employed fell to 9.22% in Q4 2025, from 4.69% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 30538.43% in Q4 2021 to a low of 527.66% in Q3 2023.
- A 5-year average of 1501.02% and a median of 27.12% in 2024 frame the typical range for Return on Capital Employed.
- The widest YoY moves for Return on Capital Employed: up 180809 bps in 2022, down 3103384 bps in 2022.
- Tracing GRDX's Return on Capital Employed over 5 years: stood at 30538.43% in 2021, then sank by 102 bps to 495.42% in 2022, then increased by 3 bps to 482.01% in 2023, then surged by 94 bps to 26.9% in 2024, then surged by 66 bps to 9.22% in 2025.
- The last three Return on Capital Employed figures came in at 9.22% (Q4 2025), 4.69% (Q3 2025), and 8.22% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -38.20% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 26.09% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -50.93% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 7.88% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -6.85% |
| 10 | GridAI Technologies | 6.06 Mn | 6.06 Mn | - | -9.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9.22% |
| Sep 30, 2025 | -4.69% |
| Jun 30, 2025 | -8.22% |
| Mar 31, 2025 | -12.98% |
| Dec 31, 2024 | -26.90% |
| Sep 30, 2024 | -26.31% |
| Jun 30, 2024 | -27.35% |
| Mar 31, 2024 | -48.58% |
| Dec 31, 2023 | -482.01% |
| Sep 30, 2023 | -527.66% |
| Jun 30, 2023 | -367.39% |
| Mar 31, 2023 | -257.11% |
| Dec 31, 2022 | -495.42% |
| Sep 30, 2022 | 895.64% |
| Jun 30, 2022 | 516.66% |
| Mar 31, 2022 | 1,541.08% |
| Dec 31, 2021 | 30,538.43% |
| Sep 30, 2021 | -501.11% |
| Jun 30, 2021 | -409.53% |
| Mar 31, 2021 | -267.01% |